Etrasimod as a treatment for eosinophilic oesophagitis (VOYAGE): a double-blind, placebo-controlled, randomised, phase 2 trial
Evan S. Dellon, Margaret H. Collins, Albert J. Bredenoord, Hamish Philpott, Luc Biedermann, Márjori Dulcine, Thai Nguyen-Cleary, Chinyu Su, Jin Yu, Huaming Tan, Fabio Cataldi, Joseph Wu, Wenjin Wang, Pamela Clax, John Woolcott, Ikuo Hirano
Topics & Concepts
Double blindPlaceboMedicineInternal medicineGastroenterologyAlternative medicinePathologyEosinophilic EsophagitisGastroesophageal reflux and treatmentsEosinophilic Disorders and Syndromes